Analysis
Cerebras Systems, the AI chipmaker that went public in May 2026 at a $56.4 billion fully diluted valuation, faces a lockup cliff of its own before the end of August: up to 84 million Class B shares become eligible to convert and sell, about 2.4 times the 34.5 million shares sold in its IPO, according to the release terms detailed in Cerebras's own S-1 and reported by market analysts tracking the filing.
An unusually front-loaded lockup structure
Most IPOs use a single, fixed 180-day lockup that releases all restricted shares at once. Cerebras's structure is different: its lockup expiration is tied to the earlier of two trading days after the company reports results for the quarter ending September 30, 2026, or the standard 180 days after its prospectus date -- an early-release mechanism rather than a single cliff. That structure meant the first earnings-linked release, up to about 27.7 million shares, came two trading days after Cerebras reported first-quarter results on June 23, and the largest single wave, about 36.4 million shares, followed second-quarter results on Aug. 12, well before a standard 180-day lockup would have expired, front-loading potential selling pressure into a narrower window than investors in a conventionally structured IPO would face.
“## An unusually front-loaded lockup structure Most IPOs use a single, fixed 180-day lockup that releases all restricted shares at once.”
The scale involved is what makes this worth tracking closely: the 84 million shares eligible to convert by end of August are about 2.4 times the 34.5 million shares sold in the IPO, and another 87 million shares unlock in September and October on top of that. Across the early-release schedule, up to about 171.1 million shares -- about five times the size of the original IPO itself -- become unrestricted before the main expiration frees all remaining shares, a supply overhang large enough to meaningfully pressure the stock if even a modest share of insiders choose to sell.
The SpaceX parallel, and the difference
This is the same dynamic Pulse covered directly this week with SpaceX's own staggered lockup schedule: a 319-million-share release pushed SpaceX shares briefly below their $135 IPO price, even though an earlier, larger 911.5-million-share release in early August had been absorbed without much disruption. The proportional scale is what differs here -- SpaceX's 319-million-share release represented a smaller fraction of its roughly 13-billion-share total float than Cerebras's 84-million-share release represents of Cerebras's much smaller public float, meaning Cerebras's coming unlock carries relatively more supply-shock risk per dollar of market cap than the SpaceX event that already moved that stock meaningfully.
The counterweight
Shares becoming eligible to sell doesn't mean insiders will actually sell all of them at once -- lockup expirations are known well in advance, and sophisticated holders often stagger their own selling to avoid moving the stock against themselves, the same dynamic that let SpaceX absorb its own larger early-August release without much price impact. Cerebras's underlying business fundamentals -- its position as one of the most credible AI-chip challengers to Nvidia, following Adit Singh's move to Mayfield built partly on the strength of that early bet -- don't change because of a scheduled supply event, and a genuinely concerning signal would be the stock failing to recover in the weeks following the release the way SpaceX's did, not the unlock happening on schedule in the first place.
